litlas
Log inCreate account

Young‐Chul Kim

Active 1993–2026

Also published as
Young Chul Kim · Young-Chul Kim
157
Papers
23,332
Citations
62
h-index
114
i10-index

Citations

Citations per year for Young‐Chul Kim1993: 2 citations1995: 5 citations1997: 1 citations1998: 3 citations1999: 7 citations2000: 2 citations2001: 8 citations2002: 4 citations2003: 14 citations2004: 5 citations2005: 18 citations2006: 40 citations2007: 44 citations2008: 37 citations2009: 35 citations2010: 35 citations2011: 32 citations2012: 30 citations2013: 71 citations2014: 102 citations2015: 190 citations2016: 259 citations2017: 232 citations2018: 370 citations2019: 1,179 citations2020: 1,404 citations2021: 1,346 citations2022: 1,025 citations2023: 807 citations2024: 1,261 citations2025: 635 citations2026: 20 citations1994: no citations, so this year is not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,028 citing papers, 22.5% of this breakdownChina: 2,558 citing papers, 19% of this breakdownUnited Kingdom: 646 citing papers, 4.8% of this breakdownJapan: 625 citing papers, 4.7% of this breakdownItaly: 612 citing papers, 4.6% of this breakdownGermany: 555 citing papers, 4.1% of this breakdownSouth Korea: 530 citing papers, 3.9% of this breakdownFrance: 509 citing papers, 3.8% of this breakdownSpain: 369 citing papers, 2.7% of this breakdownCanada: 366 citing papers, 2.7% of this breakdownNetherlands: 310 citing papers, 2.3% of this breakdownAustralia: 283 citing papers, 2.1% of this breakdown
0%22.5%Other 22.8%

Institutions

Fields

  • Medicine64.8%
  • Biochemistry, Genetics and Molecular Biology24.1%
  • Immunology and Microbiology3.3%
  • Computer Science2.3%
  • Engineering1.2%
  • Neuroscience0.9%
  • Other3.4%

Topics

  • Cancer Immunotherapy and Biomarkers9.7%
  • Lung Cancer Treatments and Mutations6.3%
  • Autophagy in Disease and Therapy3.9%
  • Lung Cancer Research Studies3.9%
  • Lung Cancer Diagnosis and Treatment3.8%
  • Hippo pathway signaling and YAP/TAZ2.4%
  • Other70%

Coauthors

All papers

Open in search
  1. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

    Authors: Scott Antonia, Augusto Villegas, Davey B. Daniel, David Vicente, Shuji Murakami, Rina Hui, Takashi Yokoi, Alberto Chiappori, Ki Hyeong Lee, Maike de Wit, Byoung Chul Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young‐Chul Kim, Christos S. Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E. Gray, Luis Paz‐Ares, Javier de Castro, Catherine Wadsworth, Giovanni Melillo, Haiyi Jiang, Yifan Huang, Phillip A. Dennis, Mustafa Özgüroğlu - New England Journal of Medicine 2017 cited by 4,539

  2. mTOR: a pharmacologic target for autophagy regulation

    Authors: Young Chul Kim, Kun‐Liang Guan - Journal of Clinical Investigation 2015 cited by 2,132

  3. Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

    Authors: Scott Antonia, Augusto Villegas, Davey B. Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki Hyeong Lee, Maike de Wit, Byoung Chul Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young‐Chul Kim, Christos S. Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E. Gray, Luis Paz‐Ares, Javier de Castro, Corinne Faivre‐Finn, Martin Reck, Johan Vansteenkiste, David R. Spigel, Catherine Wadsworth, Giovanni Melillo, Maria Taboada, Phillip A. Dennis, Mustafa Özgüroğlu - New England Journal of Medicine 2018 cited by 2,800

  4. Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations

    Authors: Paul K. Paik, Enriqueta Felip, Rémi Veillon, Hiroshi Sakai, Alexis B. Cortot, Marina Chiara Garassino, Julien Mazières, Santiago Viteri, Hélène Senellart, Jan P. van Meerbeeck, Jo Raskin, Niels Reinmuth, PierFranco Conte, Dariusz M. Kowalski, Byoung Chul Cho, Jyoti D. Patel, Leora Horn, Frank Griesinger, Ji‐Youn Han, Young‐Chul Kim, Gee‐Chen Chang, Chen‐Liang Tsai, James Chih‐Hsin Yang, Yuh-Min Chen, Egbert F. Smit, Anthonie J. van der Wekken, Terufumi Kato, Dilafruz Juraeva, Christopher Stroh, Rolf Bruns, Josef Straub, Andreas Johne, J. Scheele, John V. Heymach, Xiuning Le - New England Journal of Medicine 2020 cited by 854

  5. Differential Regulation of Distinct Vps34 Complexes by AMPK in Nutrient Stress and Autophagy

    Authors: Joungmok Kim, Young Chul Kim, Chong Fang, Ryan C. Russell, Jeong Hee Kim, Weiliang Fan, Rong Liu, Qing Zhong, Kun‐Liang Guan - Cell 2013 cited by 783

  6. Metabolic Communication by SGLT2 Inhibition

    Authors: A. Billing, Young Chul Kim, Søren Gullaksen, Benedikt Schrage, Janice Raabe, Arvid Hutzfeldt, Fatih Demir, Elina Kovalenko, Moritz Lassé, Aurélien Dugourd, Robin Fallegger, Birgit Klampe, Johannes Jaegers, Qing Li, Olha Kravtsova, Maria Crespo‐Masip, Amelia Palermo, Robert A. Fenton, Elion Hoxha, Stefan Blankenberg, Paulus Kirchhof, Tobias B. Huber, Esben Laugesen, Tanja Zeller, Maria Chrysopoulou, Julio Sáez-Rodríguez, Christina Magnussen, Thomas Eschenhagen, Alexander Staruschenko, Gary Siuzdak, Per Løgstrup Poulsen, Clarissa Schwab, Friederike Cuello, Volker Vallon, Markus M. Rinschen - Circulation 2023 cited by 133

  7. Alternative Wnt Signaling Activates YAP/TAZ

    Authors: Hyun Woo Park, Young Chul Kim, Bo Yu, Toshiro Moroishi, Jung-Soon Mo, Steven W. Plouffe, Zhipeng Meng, Kimberly C. Lin, Fa‐Xing Yu, Caroline M. Alexander, Cun-Yu Wang, Kun‐Liang Guan - Cell 2015 cited by 745

  8. Explainable heat-related mortality with random forest and SHapley Additive exPlanations (SHAP) models

    Authors: Yesuel Kim, Young‐Chul Kim - Sustainable Cities and Society 2022 cited by 331

  9. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway

    Authors: Jung-Soon Mo, Zhipeng Meng, Young Chul Kim, Hyun Woo Park, Carsten Gram Hansen, Soo-Hyun Kim, Dae‐Sik Lim, Kun‐Liang Guan - Nature Cell Biology 2015 cited by 560

  10. Differential regulation of mTORC1 by leucine and glutamine

    Authors: Jenna L. Jewell, Young Chul Kim, Ryan C. Russell, Fa‐Xing Yu, Hyun Woo Park, Steven W. Plouffe, Vincent S. Tagliabracci, Kun‐Liang Guan - Science 2015 cited by 754

  11. A role for tubular Na+/H+exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin

    Authors: Akira Ōnishi, Yiling Fu, Rohit Patel, Manjula Darshi, Maria Crespo‐Masip, Winnie Huang, Panai Song, Brent Freeman, Young Chul Kim, Manoocher Soleimani, Kumar Sharma, Scott C. Thomson, Volker Vallon - American Journal of Physiology-Renal Physiology 2020 cited by 202

  12. Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC

    Authors: Jacek Jassem, Filippo de Marinis, Giuseppe Giaccone, A. Vergnenègre, Carlos H. Barrios, Masahiro Morise, Enriqueta Felip, Cristina Oprean, Young‐Chul Kim, Zoran Andrić, Simonetta Mocci, Ida Enquist, Kimberly M. Komatsubara, Mark L. McCleland, Hiroshi Kuriki, Monette Villalobos, See Phan, David R. Spigel, Roy S. Herbst - Journal of Thoracic Oncology 2021 cited by 202

  13. Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

    Authors: Yi‐Long Wu, Ying Cheng, Jianying Zhou, Shun Lü, Yiping Zhang, Jun Zhao, Dong‐Wan Kim, Ross A. Soo, Sang‐We Kim, Hongming Pan, Yuh‐Min Chen, Chih‐Feng Chian, Xiaoqing Liu, Daniel S.W. Tan, Rolf Bruns, Josef Straub, Andreas Johne, J. Scheele, Keunchil Park, James Chih‐Hsin Yang, Yi‐Long Wu, Xiaoqing Liu, Zhe Liu, Shun Lu, Xi Chen, Hongming Pan, Mengzhao Wang, YU Shi-ying, Helong Zhang, Yiping Zhang, Jian Fang, Wei Li, Jianying Zhou, Jun Zhao, Ying Cheng, Chih-Hsin Yang, Gee‐Chen Chang, Yuh‐Min Chen, Te‐Chun Hsia, Chih‐Feng Chian, Cheng-Ta Yang, Chin‐Chou Wang, Sang‐We Kim, Keunchil Park, Dong‐Wan Kim, Byoung Chul Cho, Ki Hyeong Lee, Young‐Chul Kim, Ho Jung An, In Sook Woo, Y. Choi, Sang Won Shin, Jong Seok Lee, Joo-Hang Kim, Seung Soo Yoo, Terufumi Kato, Naofumi Shinagawa, Ross A. Soo, Shao Weng Daniel Tan, Lynette Si-Mien Ngo, Kananathan Ratnavelu, Azura Rozila Ahmad, Chong Kin Liam, Filippo de Marinis, Pierfrancesco Tassone, Amelia Insa Molla, Antonio Calles, Martín Emilio Lázaro Quintela, Enriqueta Felip Font, Anne‐Marie C. Dingemans, Lynne A. Bui - The Lancet Respiratory Medicine 2020 cited by 258

  14. Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

    Authors: Natasha B. Leighl, Hiroaki Akamatsu, Sun Min Lim, Ying Cheng, Anna Minchom, Melina E. Marmarelis, Rachel E. Sanborn, James Chih‐Hsin Yang, Baogang Liu, Thomas John, Bartomeu Massutí, Alexander I. Spira, Se‐Hoon Lee, Jialei Wang, Juan Li, Caigang Liu, Silvia Novello, Masashi Kondo, Motohiro Tamiya, Ernesto Korbenfeld, Mor Moskovitz, Ji‐Youn Han, Mariam P. Alexander, Rohit Joshi, Enriqueta Felip, Pei Jye Voon, Pongwut Danchaivijitr, Ping‐Chih Hsu, Felipe José Silva Melo Cruz, Thomas Wehler, Laurent Greillier, Encarnação Teixeira, Danny Nguyen, Joshua K. Sabari, Angel Qin, Dariusz M. Kowalski, Mehmet Alı Nahıt Şendur, John Xie, Debopriya Ghosh, Ali Alhadab, Nahor Haddish‐Berhane, Pamela L. Clemens, Patricia Lorenzini, Remy B. Verheijen, Mohamed Gamil, Joshua Bauml, Mahadi Baig, Antonio Passaro, for the PALOMA-3 Investigators, Hiroaki Akamatsu, Mariam P. Alexander, Annalen Bleckmann, Federico Cappuzzo, Ying Cheng, Byoung Chul Cho, Timuçin Çil, Alexis B. Cortot, Pongwut Danchaivijitr, Till‐Oliver Emde, Dilek Erdem, Enriqueta Felip, F. Estevinho, Maria Lurdes Ferreira, Flavio Ferreira da Silva, Maria Campelo, Laurent Greillier, Alastair Greystoke, Ji‐Youn Han, Ping‐Chih Hsu, Jen‐Yu Hung, Mei Ji, Thomas John, Rohit Joshi, Young‐Chul Kim, Masashi Kondo, Ernesto Korbenfeld, Dariusz M. Kowalski, Se‐Hoon Lee, Natasha B. Leighl, Juan Li, Sheng-Hao Lin, Baogang Liu, Caigang Liu, John Seng-Hooi Low, Melina E. Marmarelis, Bartomeu Massutí, Anna R. Minchom, Sara Moore, Mor Moskovitz, Adnan Nagrial, Danny Nguyen, Silvia Novello, Y. Ohe, Mustafa Özgüroğlu, Özgür Özyılkan, Antonio Passaro, Nir Peled, Naiyarat Prasongsook, Angel Qin, Elisa F. Ramos and 22 more - Journal of Clinical Oncology 2024 cited by 114

  15. Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes

    Authors: Morganna Freeman-Keller, Young‐Chul Kim, Heather Cronin, Allison Richards, Geoffrey T. Gibney, Jeffrey S. Weber - Clinical Cancer Research 2015 cited by 875

  16. Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

    Authors: Marina Chiara Garassino, Byoung Chul Cho, Joo-Hang Kim, Julien Mazières, Johan Vansteenkiste, H. Léna, Jesus Corral Jaime, Jhanelle E Gray, John D. Powderly, C. Chouaïd, Paolo Bidoli, Paul Wheatley‐Price, Keunchil Park, Ross A. Soo, Yifan Huang, Catherine Wadsworth, Phillip A. Dennis, Naiyer A. Rizvi, Luis Paz-Ares Rodríguez, Silvia Novello, Sandrine Hiret, Peter Schmid, Eckart Laack, Raffaele Califano, Makoto Maemondo, Sang‐We Kim, Jamie E. Chaft, David Vicente Baz, Thierry Berghmans, Dong‐Wan Kim, Veerle Surmont, Martin Reck, Ji‐Youn Han, Esther Holgado Martin, Cristóbal Belda-Iniesta, Yuichiro Oe, Antonio Chella, Akhil Chopra, G. Robinet, Héctor Soto Parrà, Michael J. Thomas, Parneet Cheema, Nobuyuki Katakami, Wu‐Chou Su, Young‐Chul Kim, Juergen Wolf, Jong-Seok Lee, Hideo Saka, Michele Stanislaw Milella, Inmaculada Ramos García, Anne Sibille, Takashi Yokoi, Eun Joo Kang, Shinji Atagi, E. Spaeth-Schwalbe, Makoto Nishio, Fumio Imamura, Nashat Gabrail, Rémi Veillon, Sofie Derijcke, Tadashi Maeda, Dylan M. Zylla, Kendra Kubiak, Armando Santoro, Ma. Noemi Uy, Sarayut Lucien Geater, Antoîne Italiano, Dariusz M. Kowalski, Fabrice Barlési, Yuh‐Min Chen, David R. Spigel, Busyamas Chewaskulyong, Ramón García Gómez, Rosa Álvarez, Chih-Hsin Yang, Te‐Chun Hsia, Fabrice Denis, Hiroshi Sakai, Mark Vincent, Kōichi Goto, Joaquim Bosch‐Barrera, Glen J. Weiss, Jean-Luc Canon, Christian W. Scholz, Massimo Aglietta, Hirotsugu Kemmotsu, Koichi Azuma, Penelope A. Bradbury, Ronald Feld, Abraham Chachoua, Jacek Jassem, Rosalyn A. Juergens, Ramon Palmero Sanchez, Albert Malcolm, Nandagopal Vrindavanam, Kaoru Kubota, Cornelius F. Waller, David Waterhouse, Bruno Coudert, Z. Mark and 52 more - The Lancet Oncology 2018 cited by 576

  17. KRYSTAL-12: Phase 3 study of adagrasib versus docetaxel in patients with previously treated advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation.

    Authors: Tony Mok, Wenxiu Yao, M. Duruisseaux, Ludovic Doucet, Aitor Azkárate Martínez, Vanesa Gregorc, Óscar Juan, Shun Lu, Charlotte De Bondt, Filippo de Marinis, Helena Linardou, Young‐Chul Kim, Robert M. Jotte, Enriqueta Felip, Giuseppe Lo Russo, Martin Reck, Mary F. Michenzie, Wenjing Yang, Julie Nicole Meade, Fabrice Barlési - Journal of Clinical Oncology 2024 cited by 70

  18. ARC-7: Randomized phase 2 study of domvanalimab + zimberelimab ± etrumadenant versus zimberelimab in first-line, metastatic, PD-L1-high non-small cell lung cancer (NSCLC).

    Authors: Melissa L. Johnson, W. Fox, Yun‐Gyoo Lee, Ki Hyeong Lee, Hee Kyung Ahn, Young‐Chul Kim, Kang‐Yun Lee, Jong-Seok Lee, He Xian, Christine Park, Debbie Pomponio, Thao Dang, Patrick Hoang Phuong, Dimitry S.A. Nuyten, Aparna Hegde, Rohit Joshi - Journal of Clinical Oncology 2022 cited by 57

  19. Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP

    Authors: Fa‐Xing Yu, Jing Luo, Jung‐Soon Mo, Guangbo Liu, Young Chul Kim, Zhipeng Meng, Ling Zhao, Gholam A. Peyman, Hong Ouyang, Wei Jiang, Jiagang Zhao, Xu Chen, Liangfang Zhang, Cun‐Yu Wang, Boris C. Bastian, Kang Zhang, Kun‐Liang Guan - Cancer Cell 2014 cited by 458

  20. Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors

    Authors: Da Hyun Kang, Cheol‐Kyu Park, Chaeuk Chung, In‐Jae Oh, Young‐Chul Kim, Dongil Park, Jinhyun Kim, Gye Cheol Kwon, In‐Sun Kwon, Pureum Sun, Eui‐Cheol Shin, Jeong Eun Lee - Immune Network 2020 cited by 76

  21. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

    Authors: Jianxin Shi, Kouya Shiraishi, Jiyeon Choi, Keitaro Matsuo, Tzu-Yu Chen, Juncheng Dai, Rayjean J. Hung, Kexin Chen, Xiao‐Ou Shu, Young Tae Kim, Maria Teresa Landi, Dongxin Lin, Wei Zheng, Zhihua Yin, Baosen Zhou, Bao Song, Jiucun Wang, Wei Jie Seow, Lei Song, I‐Shou Chang, Wei Hu, Li-Hsin Chien, Qiuyin Cai, Yun‐Chul Hong, Hee Nam Kim, Yi‐Long Wu, Maria Pik Wong, Brian Richardson, Karen Funderburk, Shilan Li, Tongwu Zhang, Charles E. Breeze, Zhaoming Wang, Batel Blechter, Bryan A. Bassig, Jin Hee Kim, Demetrius Albanes, Jason Y.Y. Wong, Min‐Ho Shin, Lap Ping Chung, Yang Yang, Shejuan An, Hong Zheng, Yasushi Yatabe, Xu‐Chao Zhang, Young‐Chul Kim, Neil E. Caporaso, Jiang Chang, Jcm Ho, Michiaki Kubo, Yataro Daigo, Minsun Song, Yukihide Momozawa, Yoichiro Kamatani, Masashi Kobayashi, Kenichi Okubo, Takayuki Honda, Dean Hosgood, Hideo Kunitoh, Harsh Patel, Shun‐ichi Watanabe, Yohei Miyagi, Haruhiko Nakayama, Shingo Matsumoto, Hidehito Horinouchi, Masahiro Tsuboi, Ryuji Hamamoto, Kōichi Goto, Yuichiro Ohe, Atsushi Takahashi, Akiteru Goto, Yoshihiro Minamiya, Megumi Hara, Yuichiro Nishida, Kenji Takeuchi, Kenji Wakai, Koichi Matsuda, Yoshinori Murakami, Kimihiro Shimizu, Hiroyuki Suzuki, Motonobu Saito, Yoichi Ohtaki, Kazumi Tanaka, Tangchun Wu, Fusheng Wei, Hong Dai, Mitchell J. Machiela, Jian Su, Yeul Hong Kim, In‐Jae Oh, Victor Lee, Gee‐Chen Chang, Ying‐Huang Tsai, Kuan‐Yu Chen, Ming‐Shyan Huang, Wu‐Chou Su, Yuh‐Min Chen, Adeline Seow, Jae Yong Park, Sun‐Seog Kweon and 122 more - Nature Communications 2023 cited by 70

  22. Sestrins Inhibit mTORC1 Kinase Activation through the GATOR Complex

    Authors: Anita Parmigiani, Aida Nourbakhsh, Boxiao Ding, Wei Wang, Young Chul Kim, Konstantin Akopiants, Kun‐Liang Guan, Michael Karin, Andrei V. Budanov - Cell Reports 2014 cited by 326

  23. Varying Appearances of Cholangiocarcinoma: Radiologic-Pathologic Correlation

    Authors: Yong Eun Chung, Myeong‐Jin Kim, Young Nyun Park, Jin‐Young Choi, Ju Yeon Pyo, Young Chul Kim, Hyeon Je Cho, Kyung‐Ah Kim, Sun Young Choi - Radiographics 2009 cited by 449

  24. Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients

    Authors: Young-Wook Kim, Peter S. Hammerman, Jaegil Kim, Ji-ae Yoon, Yoomi Lee, Jong‐Mu Sun, Matthew D. Wilkerson, Chandra Sekhar Pedamallu, Kristian Cibulskis, Yeong Kyung Yoo, Michael S. Lawrence, Petar Stojanov, Scott L. Carter, Aaron McKenna, Chip Stewart, Andrey Sivachenko, In‐Jae Oh, Hong Kwan Kim, Yong Soo Choi, Kwhanmien Kim, Young Mog Shim, Kyu-Sik Kim, Sang-Yun Song, Kook-Joo Na, Yoon‐La Choi, D. Neil Hayes, Jhingook Kim, Sukki Cho, Young‐Chul Kim, Jin Seok Ahn, Myung‐Ju Ahn, Gad Getz, Matthew Meyerson, Keunchil Park - Journal of Clinical Oncology 2013 cited by 204